Source: Virtual Congress 2021 – Pathophysiology and clinical consequences of obstructive sleep apnoea



Rating:

Share or cite this content

Citations should be made in the following way:
D. Krasimirova (Sofia, Bulgaria), V. Pencheva (Sofia, Bulgaria), O. Georgiev (Sofia, Bulgaria), D. Petrova (Sofia, Bulgaria), R. Bilyukov (Sofia, Bulgaria), T. Mondeshki (Sofia, Bulgaria), S. Naydenska (Sofia, Bulgaria), P. Shoshkov (Sofia, Bulgaria), A. Tzakova (Sofia, Bulgaria). Bone metabolism and fracture risk in obstructive sleep apnea. 366

Member's Comments

No comment yet.

Related content which might interest you: Association between childhood obstructive sleep apnoea and risk of early osteoporosis. Source: International Congress 2019 – Evaluation of breathing in children when they are asleep, healthy or ill Year: 2019 Bone mass loss and risk of fractures on both gender sleep apnoea patients Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Cardiovascular and metabolic consequences of obstructive sleep apnoea Source: Eur Respir J 2001; 18: Suppl. 33, 519s Year: 2001 Obstructive sleep apnoea and bone health Source: Eur Respir J 2016; 48: 1249-1250 Year: 2016 Obstructive sleep apnoea and bone health Source: Eur Respir J 2016; 48: 1248-1249 Year: 2016 Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease Source: Eur Respir J 2013; 41: 616-620 Year: 2013 Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population Source: Eur Respir J 2016; 47: 987-990 Year: 2016 Independent association between obstructive sleep apnea severity and liver stiffness Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018 Cardiovascular morbidity in obstructive sleep apnoea Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts Year: 2009 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Cortisol metabolism in obstructive sleep apnea (OSA) Source: Eur Respir J 2002; 20: Suppl. 38, 215s Year: 2002 Cardiovascular morbidity and obstructive sleep apnoea in children Source: Annual Congress 2009 - Current developments in sleep-disordered breathing in children Year: 2009 The metabolic consequences of obstructive sleep apnoea in children Source: Breathe 2009; 6: 111-114 Year: 2009 Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders Year: 2007 Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008 Association between obstructive sleep apnoea (OSA) severity and metabolic disturbances Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017 Obstructive sleep apnoea and metabolic impairment in severe obesity Source: Eur Respir J 2011; 38: 1089-1097 Year: 2011